These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 211503)

  • 41. Murine leukemia virus envelope gp70 is a shared biomarker for the high-sensitivity quantification of murine tumor burden.
    Scrimieri F; Askew D; Corn DJ; Eid S; Bobanga ID; Bjelac JA; Tsao ML; Allen F; Othman YS; Wang SC; Huang AY
    Oncoimmunology; 2013 Nov; 2(11):e26889. PubMed ID: 24482753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex.
    Opstelten DJ; Wallin M; Garoff H
    J Virol; 1998 Aug; 72(8):6537-45. PubMed ID: 9658097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the TM protein of Rous sarcoma virus in the absence of SU shows that this domain is capable of oligomerization and intracellular transport.
    Einfeld DA; Hunter E
    J Virol; 1994 Apr; 68(4):2513-20. PubMed ID: 8139033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation of BPgp70, a fibroblast receptor for the envelope antigen of Rauscher murine leukemia virus.
    Landen B; Fox CF
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4988-92. PubMed ID: 6933542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Murine mammary tumor virus structural protein interactions: formation of oligomeric complexes with cleavable cross-linking agents.
    Racevskis J; Sarkar NH
    J Virol; 1980 Sep; 35(3):937-48. PubMed ID: 6252348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1.
    Pinter A; Honnen WJ; Tilley SA; Bona C; Zaghouani H; Gorny MK; Zolla-Pazner S
    J Virol; 1989 Jun; 63(6):2674-9. PubMed ID: 2786089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
    Earl PL; Doms RW; Moss B
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):648-52. PubMed ID: 2300552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nearest-neighbor interactions of the major RNA tumor virus glycoprotein on murine cell surfaces.
    Takemoto LJ; Fox CF; Jensen FC; Elder JH; Lerner RA
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3644-8. PubMed ID: 211503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural studies of retroviruses: characterization of oligomeric complexes of murine and feline leukemia virus envelope and core components formed upon cross-linking.
    Pinter A; Fleissner E
    J Virol; 1979 Apr; 30(1):157-65. PubMed ID: 225513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiserum to murine leukemia virus recognizes novel cell surface molecules associated with growth control and transformation.
    Rieber M; Rieber M; Alonso M
    Int J Cancer; 1979 Apr; 23(4):547-54. PubMed ID: 86526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship of GIX antigen expression to the glycosylation of murine leukemia virus glycoprotein.
    Rosner MR; Tung JS; Hopkins N; Robbins PW
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6420-4. PubMed ID: 6935656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in glycosylation patterns of closely related murine leukemia viruses.
    Rosner MR; Grinna LS; Robbins PW
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):67-71. PubMed ID: 6244574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemical crosslinking of major structural proteins within type D retroviruses.
    Uckert W; Westermann P; Hertling I; Wunderlich V
    Biomed Biochim Acta; 1983; 42(2-3):177-87. PubMed ID: 6882406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies in antibody response of mice to tumour inoculation.
    GORER PA
    Br J Cancer; 1950 Dec; 4(4):372-9. PubMed ID: 14801344
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.